Company logo

PRGO - Perrigo Company plc

NYSE -> Healthcare -> Drug Manufacturers—Specialty & Generic
Dublin, Ireland
Type: Equity

PRGO price evolution
PRGO
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $751.3 $598.3 $555.2 $553
Short term investments
Net receivables $739.6 $737.8 $754.1 $738.7
Inventory $1140.9 $1149.5 $1167.5 $1183
Total current assets $2832.9 $2765.3 $2773 $2740.7
Long term investments
Property, plant & equipment $1100 $1102.8 $1125.2 $1131
Goodwill & intangible assets $6515.2 $6496.1 $6688.6 $6734.3
Total noncurrent assets $7976.2 $7993 $8191.7 $8214.2
Total investments
Total assets $10809.1 $10758.3 $10964.7 $10954.9
Current liabilities
Accounts payable $477.7 $433.1 $470.5 $505.2
Deferred revenue
Short long term debt $440.6 $38.1 $38.4 $38.8
Total current liabilities $1586.3 $1008.4 $1056.9 $1086.8
Long term debt $3632.8 $4048.5 $4055.9 $4062.8
Total noncurrent liabilities $4454.9 $5011.8 $5059.2 $5034.2
Total debt $4073.4 $4086.6 $4094.3 $4101.6
Total liabilities $6041.2 $6020.2 $6116.1 $6121
Shareholders' equity
Retained earnings -$2080.3 -$2048 -$2062.2 -$2070.6
Other shareholder equity $10.7 -$78.1 $19.9 -$6.3
Total shareholder equity $4767.9 $4738.1 $4848.6 $4833.9
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $751.3 $600.7 $1864.9 $641.5
Short term investments $2.5
Net receivables $739.6 $738.6 $652.9 $1054.2
Inventory $1140.9 $1150.3 $1020.2 $1200.2
Total current assets $2832.9 $2719.9 $3859.9 $3133.5
Long term investments $71.7
Property, plant & equipment $1100 $1165.4 $1031 $1182
Goodwill & intangible assets $6515.2 $6779.2 $5150.8 $6758.2
Total noncurrent assets $7976.2 $8297.4 $6565.8 $8354.9
Total investments
Total assets $10809.1 $11017.3 $10425.7 $11488.4
Current liabilities
Accounts payable $477.7 $537.3 $411.2 $543.8
Deferred revenue
Short long term debt $440.6 $36.2 $603.8 $37.8
Total current liabilities $1586.3 $1113.6 $1587.9 $1382
Long term debt $3632.8 $4070.4 $2916.7 $3528.3
Total noncurrent liabilities $4454.9 $5061.6 $3686.1 $4451.3
Total debt $4073.4 $4106.6 $3520.5 $3566.1
Total liabilities $6041.2 $6175.2 $5274 $5833.3
Shareholders' equity
Retained earnings -$2080.3 -$2067.6 -$1927 -$1858.1
Other shareholder equity $10.7 -$27 $35.5 $395
Total shareholder equity $4767.9 $4842.1 $5151.7 $5655.1
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $1156.9 $1123.8 $1193.1 $1181.7
Cost of revenue $729.6 $712.6 $765.1 $767.9
Gross Profit $427.3 $411.2 $428 $413.8
Operating activities
Research & development $29.6 $29.6 $32.2 $31.1
Selling, general & administrative $281.3 $276.2 $303.7 $302.9
Total operating expenses $442.9 $349.1 $371.2 $365.3
Operating income -$15.6 $62.1 $56.8 $48.5
Income from continuing operations
EBIT -$16.2 $61.5 $66 $46.1
Income tax expense -$26.6 $3.8 $13.6 $5.4
Interest expense $42.7 $43.5 $44 $43.7
Net income
Net income -$32.3 $14.2 $8.4 -$3
Income (for common shares) -$32.3 $14.2 $8.4 -$3
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $4655.6 $4451.6 $4138.7 $5063.3
Cost of revenue $2975.2 $2996.2 $2722.5 $3248.1
Gross Profit $1680.4 $1455.4 $1416.2 $1815.2
Operating activities
Research & development $122.5 $123.1 $122 $177.7
Selling, general & administrative $1164.1 $1097.1 $1018.4 $1075.1
Total operating expenses $1528.5 $1376.5 $1005.8 $1699.8
Operating income $151.9 $78.9 $410.4 $115.4
Income from continuing operations
EBIT $157.2 $7.2 $445.7 -$18.2
Income tax expense -$3.9 -$8.2 $389.6 $13.2
Interest expense $173.8 $156 $125 $131.2
Net income
Net income -$12.7 -$140.6 -$68.9 -$162.6
Income (for common shares) -$12.7 -$140.6 -$68.9 -$162.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$32.3 $14.2 $8.4 -$3
Operating activities
Depreciation $85.9 $91 $93.9 $88.7
Business acquisitions & disposals $4.4
Stock-based compensation $10.6 $14.7 $18.6 $24.9
Total cash flows from operations $208.7 $124.5 $52.9 $19.4
Investing activities
Capital expenditures -$28.7 -$31.6 -$20 -$21.4
Investments
Total cash flows from investing -$22.8 -$30.7 -$4.4 -$19.6
Financing activities
Dividends paid -$37.6 -$38.9 -$37 -$36.2
Sale and purchase of stock
Net borrowings -$6.2 -$9.1 -$9 -$5.9
Total cash flows from financing -$44.6 -$43.3 -$48.6 -$50.7
Effect of exchange rate $11.7 -$7.4 $2.3 $3.2
Change in cash and equivalents $153 $43.1 $2.2 -$47.7
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$12.7 -$140.6 -$68.9 -$162.6
Operating activities
Depreciation $359.5 $338.6 $312.2 $384.8
Business acquisitions & disposals $4.4 -$1865.5 $1421.3 -$15.9
Stock-based compensation $68.8 $54.9 $60.1 $58.5
Total cash flows from operations $405.5 $307.3 $156.3 $636.2
Investing activities
Capital expenditures -$101.7 -$96.4 -$152.1 -$170.4
Investments -$15
Total cash flows from investing -$77.5 -$1958.6 $1275.8 -$187.8
Financing activities
Dividends paid -$149.7 -$142.4 -$129.6 -$123.9
Sale and purchase of stock -$164.2
Net borrowings -$30.2 $604.5 -$30.6 $130.9
Total cash flows from financing -$187.2 $421.6 -$178.7 -$181.1
Effect of exchange rate $9.8 -$48.9 -$15.6 $19.9
Change in cash and equivalents $150.6 -$1278.6 $1237.8 $287.2
Fundamentals
Market cap $4.36B
Enterprise value $7.68B
Shares outstanding 135.50M
Revenue $4.66B
EBITDA $516.90M
EBIT $157.40M
Net Income -$12.70M
Revenue Q/Q 0.14%
Revenue Y/Y 5.19%
P/E ratio -343.44
EV/Sales 1.65
EV/EBITDA 14.87
EV/EBIT 48.82
P/S ratio 0.94
P/B ratio 0.92
Book/Share 35.11
Cash/Share 5.54
EPS -$0.09
ROA -0.12%
ROE -0.26%
Debt/Equity 1.27
Net debt/EBITDA 10.23
Current ratio 1.79
Quick ratio 1.07